Related Experiment Video
Updated: Jul 30, 2026
06:51
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Estrogen replacement in perimenopause-related depression: a preliminary report
P J Schmidt1, L Nieman, M A Danaceau
1Behavioral Endocrinology Branch, National Institute of Mental Health, Bethesda, MD 20892-1276, USA.
American Journal of Obstetrics and Gynecology
|August 15, 2000
Summary
Estrogen therapy effectively treats perimenopausal depression, significantly improving mood and reducing symptoms. This treatment is effective regardless of hot flashes or treatment duration.
Area of Science:
- Reproductive Endocrinology
- Psychiatry
- Clinical Pharmacology
Background:
- Perimenopausal depression is a common condition affecting women during hormonal transition.
- Vasomotor symptoms like hot flashes often accompany perimenopausal depression.
- The efficacy of estrogen in treating depression in this population requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of 17beta-estradiol in treating depression among perimenopausal women.
- To determine if estrogen's antidepressant effects are linked to its impact on hot flashes.
- To assess the influence of treatment duration on therapeutic outcomes.
Main Methods:
- A double-blind, parallel-design randomized controlled trial was conducted.
- Participants with perimenopausal depression received either 17beta-estradiol or a placebo for 3 weeks.
- Mood and symptom severity were assessed using standardized scales and a visual analog scale.
Main Results:
- Estrogen treatment led to significant reductions in depression scores compared to placebo (P <.01).
- 80% of women receiving estradiol showed a therapeutic response, versus 22% on placebo.
- The presence of hot flashes and treatment duration did not affect the antidepressant efficacy of estradiol.
Conclusions:
- 17beta-estradiol is an effective treatment for perimenopausal depression.
- Estrogen's antidepressant benefits are independent of its effects on vasomotor symptoms.
- This preliminary study suggests estradiol replacement therapy as a viable option for perimenopausal depression.
More Related Videos
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...